Intrinsiqq
Roivant Sciences Ltd logo

Roivant Sciences Ltd Dividend Analysis

ROIV

⊜ Compare
Dividend0
No active dividend

This company has no dividend history.

Based on TTM and annual data · Not a buy/sell signal

This company does not pay dividends

No dividend history found in SEC filings.

Does Roivant Sciences (ROIV) pay a dividend?

Roivant Sciences (ROIV) has never paid a dividend. It returns cash through buybacks instead, at roughly a 4.7% buyback yield over the last twelve months. Free cash flow is currently negative, so there is no surplus to distribute. All figures are computed from company filings; this is analysis, not investment advice.

Frequently asked

Does Roivant Sciences (ROIV) pay a dividend?+

No. Roivant Sciences (ROIV) does not pay a dividend, and no dividend payment appears anywhere in the filing history we hold.

How does Roivant Sciences return cash to shareholders?+

Through share buybacks rather than dividends. Over the last twelve months Roivant Sciences reduced its share count at a rate equivalent to a 4.7% buyback yield. A buyback returns value by shrinking the share count, so each remaining share owns more of the business, but unlike a dividend it pays you nothing in cash and can be stopped at any time without an announcement.

Could Roivant Sciences afford to pay a dividend?+

Not currently. Roivant Sciences's free cash flow is negative at -$821 million, meaning the business consumed cash over the period rather than generating it. A company funding a dividend from cash it is not producing would be paying shareholders out of its balance sheet or borrowings, which is not sustainable.

Which healthcare companies do pay dividends?+

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Roivant Sciences.

SourceDividend analysis computed from the 10-Q filed 31 Jul 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 7 Aug 2026. How this is calculated.

Fiscal year ends Mar. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ROIV

CompareIntrinsic value
KYNBKyntra Bio, Inc.
$3.96-8.12%20
ADAGAdagene Inc.
$2.41+2.55%25
COYACoya Therapeutics Inc.
$3.08-0.96%10
OVIDOvid Therapeutics Inc.
$2.74+14.17%25
NAMSNewAmsterdam Pharma Co. N.V.
$20.93+5.18%10
ACRSAclaris Therapeutics, Inc.
$3.68-1.60%10
ALMSAlumis Inc.
$6.55+0.77%10
HCWBHCW Biologics Inc.
$1.08-6.09%15

Held by ETFs

ROIV is in 142 US ETFs. The largest of them, with ROIV's weight in each:

Spot a number that looks wrong? Check it in ROIV's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ROIV

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.